11.78
Overview
News
Price History
Option Chain
Financials
Why CC Down?
Discussions
Forecast
Dividend History
Chemours Company stock is traded at $11.78, with a volume of 370.94K.
It is up +0.30% in the last 24 hours and down -0.63% over the past month.
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
See More
Previous Close:
$11.78
Open:
$11.79
24h Volume:
370.94K
Relative Volume:
0.13
Market Cap:
$1.77B
Revenue:
$5.75B
Net Income/Loss:
$77.00M
P/E Ratio:
24.04
EPS:
0.49
Net Cash Flow:
$-675.00M
1W Performance:
-4.72%
1M Performance:
-0.63%
6M Performance:
+8.00%
1Y Performance:
-37.02%
Chemours Company Stock (CC) Company Profile
Name
Chemours Company
Sector
Industry
Phone
302 773 1000
Address
1007 MARKET STREET, WILMINGTON, DE
Compare CC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CC
Chemours Company
|
11.79 | 1.77B | 5.75B | 77.00M | -675.00M | 0.49 |
|
LIN
Linde plc Ordinary Share
|
417.46 | 194.71B | 33.50B | 7.25B | 5.08B | 14.94 |
|
SHW
Sherwin Williams Co
|
327.79 | 81.42B | 23.28B | 2.57B | 2.43B | 10.24 |
|
ECL
Ecolab Inc
|
260.02 | 73.96B | 15.89B | 2.00B | 1.55B | 6.9525 |
|
APD
Air Products Chemicals Inc
|
241.54 | 54.54B | 12.04B | -346.40M | -3.77B | -1.7734 |
|
PPG
Ppg Industries Inc
|
104.14 | 23.27B | 16.18B | 1.32B | 807.00M | 5.6399 |
Chemours Company Stock (CC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-25 | Upgrade | Mizuho | Neutral → Outperform |
| Jan-28-25 | Initiated | Truist | Buy |
| Jul-09-24 | Upgrade | UBS | Neutral → Buy |
| Jun-07-24 | Initiated | Mizuho | Neutral |
| Apr-09-24 | Upgrade | BMO Capital Markets | Underperform → Outperform |
| Mar-05-24 | Downgrade | UBS | Buy → Neutral |
| Feb-29-24 | Downgrade | BMO Capital Markets | Outperform → Underperform |
| Dec-01-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-22-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-23 | Upgrade | UBS | Neutral → Buy |
| Jan-11-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-10-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-01-22 | Initiated | Credit Suisse | Underperform |
| Oct-13-22 | Initiated | Goldman | Neutral |
| Oct-05-22 | Downgrade | Argus | Buy → Hold |
| Jun-14-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-10-21 | Initiated | Wolfe Research | Outperform |
| Jun-09-21 | Upgrade | Goldman | Neutral → Buy |
| May-20-21 | Initiated | BofA Securities | Buy |
| May-06-21 | Upgrade | Argus | Hold → Buy |
| Jan-08-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-04-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-30-20 | Initiated | Alembic Global Advisors | Overweight |
| Mar-23-20 | Downgrade | Jefferies | Buy → Hold |
| Feb-14-20 | Upgrade | CFRA | Buy → Strong Buy |
| Nov-06-19 | Upgrade | CFRA | Hold → Buy |
| Aug-20-19 | Upgrade | Susquehanna | Neutral → Positive |
| Aug-09-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-06-19 | Downgrade | Argus | Buy → Hold |
| Aug-05-19 | Downgrade | SunTrust | Buy → Hold |
| Jul-12-19 | Downgrade | Citigroup | Buy → Neutral |
| May-06-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-15-19 | Upgrade | SunTrust | Hold → Buy |
| Feb-19-19 | Downgrade | Susquehanna | Positive → Neutral |
| Jan-08-19 | Initiated | HSBC Securities | Buy |
| Jan-04-19 | Upgrade | Citigroup | Neutral → Buy |
| Nov-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jul-18-18 | Initiated | RBC Capital Mkts | Outperform |
| Jan-30-18 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-06-17 | Downgrade | Goldman | Buy → Neutral |
| Aug-07-17 | Upgrade | UBS | Sell → Neutral |
View All
Chemours Company Stock (CC) Latest News
The Chemours Company $CC Stake Decreased by Luminus Management LLC - MarketBeat
What Chemours (CC)'s New Titanium Technologies President Means For Its Operations‑First Strategy - simplywall.st
Chemours (NYSE:CC) Stock Price Down 7.5%Here's Why - MarketBeat
Chemours Company (CC) Up More than 12% Since Q3, Here's What Wall Street Thinks About the Stock - Finviz
Chemours Company (CC) up more than 12% since Q3, here’s what Wall Street thinks about the stock - MSN
Chemours Company (CC) Up More than 12% Since Q3, Here’s What Wall Street Thinks About the Stock - Insider Monkey
The Chemours Company (NYSE:CC) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Chemours Taps Industry Veteran to Lead Titanium Unit Through Next Phase - MyChesCo
The Chemours Company $CC Shares Acquired by Vision One Management Partners LP - MarketBeat
Experts issue warning after discovering dangerous substance in US water supply: '[They're] permitting someone to put something into the … water' - The Cool Down
Expanded PTFE Market Report 2025: Trends, Forecast and Competitive Analysis to 2031 with Profiles on - pharmiweb.com
Expanded PTFE Market Report 2025: Trends, Forecast and Competitive Analysis to 2031 with Profiles on The Chemours Company, 3M Company, Saint-Gobain, Nitto Denko, ArkemaResearchAndMarkets.com - Business Wire
The forever chemical TFA could cause irreversible harm. In Eastern North Carolina, it’s everywhere. - NC Newsline
Scientists Say This Chemical Could Cause Irreversible Harm. It's Everywhere in Eastern N.C. - The Assembly NC
Scientists say the 'forever chemical' TFA causes irreversible harm. In eastern NC, it's everywhere. - Cardinal & Pine
JPMorgan reduces PT on The Chemours Company (CC) to $13 from $15, keeps a neutral rating - MSN
Spotlight On Chemours’ Expansion Plans - WilmingtonBiz
Scientists Say the Forever Chemical TFA Could Cause Irreversible Harm. In Eastern North Carolina, It’s Everywhere. - Inside Climate News
NJ Slams Town's Bid To 'Unilaterally Rewrite' PFAS Deal - Law360
How a Kentucky water plant tracked the spike in a 'forever chemical' - NPR
Chemours cannot keep documents sealed, federal judge rules - North Carolina Health News
JPMorgan Reduces PT on The Chemours Company (CC) to $13 From $15, Keeps a Neutral Rating - Yahoo Finance
The Chemours Company $CC Stock Position Cut by Marshall Wace LLP - MarketBeat
Assessing Chemours (CC) Valuation After Prolonged Share Price Weakness and Litigation Concerns - Yahoo Finance
Chemours (NYSE:CC) Stock Price Up 6.1%What's Next? - MarketBeat
Hsbc Holdings PLC Buys Shares of 398,271 The Chemours Company $CC - MarketBeat
How Investors Are Reacting To Chemours (CC) Appointing Michael Foley To Lead Titanium Technologies - simplywall.st
How risky is The Chemours Company (2CU) stock compared to peersJuly 2025 Retail & Daily Oversold Bounce Ideas - Newser
Why Chemours Company (The) stock could outperform next yearMarket Movers & Proven Capital Preservation Methods - Newser
Chemours appoints Michael Foley as president of titanium technologies By Investing.com - Investing.com Nigeria
Tiny N.J. township wins appeal to pursue $1 billion cleanup lawsuit over toxic waste - Yahoo
Chemours appoints Michael Foley as president of titanium technologies - Investing.com
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel - Bluefield Daily Telegraph
Will The Chemours Company (2CU) stock benefit from Fed rate cutsJuly 2025 Market Mood & Accurate Intraday Trade Tips - Newser
JPMorgan Chase & Co. Has Lowered Expectations for Chemours (NYSE:CC) Stock Price - MarketBeat
Quantbot Technologies LP Has $3.64 Million Position in The Chemours Company $CC - MarketBeat
Why Chemours Company (The) stock stays on buy listsWeekly Trade Review & High Win Rate Trade Alerts - Newser
Will The Chemours Company stock continue dividend increasesWeekly Volume Report & Technical Analysis for Trade Confirmation - Newser
Assessing Chemours (CC) Valuation After Recent Short-Term Share Price Rebound - simplywall.st
Chemours Company (The) (CC) Stock Forecasts - Yahoo Finance
Chemours Monopolizing Refrigerant Market, Court Told - Law360
Carneys Point Township Given Go-Ahead to Pursue Litigation Against DuPont, Chemours - Law.com
JP Morgan Lowers Chemours (CC) Price Target to $13.00 | CC Stock News - GuruFocus
Opacifiers Market Size, Trends Analysis 2030 by Key Vendors- - openPR.com
JPMorgan Chase & Co. Sells 2,145,222 Shares of The Chemours Company $CC - MarketBeat
Brunswick Co. commissioners unanimously opposed Chemours’ Fayetteville expansion - WECT
DuPont, Chemours Lose Appeal to Avoid NJ Township’s Waste Case - Bloomberg Law News
Assessing Chemours After Leadership Changes and an 11.7% Weekly Stock Surge - simplywall.st
Chemours' Approach to Circularity - ACCESS Newswire
Will The Chemours Company stock pay special dividendsBuy Signal & Risk Controlled Stock Alerts - Newser
Chemours Company Stock (CC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):